Inventor
XU GUOZHANG
US31 patents
⚠️ This page may combine multiple inventors who share the name “XU GUOZHANG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
JANSSEN PHARMACEUTICA NV
21 patentsUS8013153B2Sep 6, 2011
Substituted pyrimidine kinase inhibitors
JANSSEN PHARMACEUTICA NV14 citations76
US10214493B2Feb 26, 2019
Indazole derivatives useful as glucagon receptor antagonists
JANSSEN PHARMACEUTICA NV3 citations72
US10000473B2Jun 19, 2018
Indazole derivatives useful as glucagon receptor antagonists
JANSSEN PHARMACEUTICA NV3 citations72
US11098016B2Aug 24, 2021
Indazole derivatives useful as glucagon receptor antagonists
JANSSEN PHARMACEUTICA NV0 citations62
US11014917B2May 25, 2021
5-fluoro-c-(aryl or heterocyclyl)-glycoside derivatives useful as dual SGLT1 / SGLT2 modulators
JANSSEN PHARMACEUTICA NV0 citations62
US12545677B2Feb 10, 2026
Compounds useful as factor XIa inhibitors
JANSSEN PHARMACEUTICA NV0 citations61
US7846953B2Dec 7, 2010
Substituted phenoxy thiazolidinediones as estrogen related receptor-α modulators
JANSSEN PHARMACEUTICA NV3 citations59
US12286429B2Apr 29, 2025
5-oxo-1,2,3,5,8,8a-hexahydroindolizine-3-carboxamide derivatives useful as a factor XIa inhibitors
JANSSEN PHARMACEUTICA NV0 citations52
US11958856B2Apr 16, 2024
Substituted 1,2,3,8,9,9a-hexahydro-5H-pyrrolo[1,2-a]azepin-5-ones as factor XIa inhibitors
JANSSEN PHARMACEUTICA NV0 citations51
US10774048B2Sep 15, 2020
Indazole derivatives useful as glucagon receptor antagonists
JANSSEN PHARMACEUTICA NV0 citations51
US10696662B2Jun 30, 2020
5-fluoro-C-(aryl or heterocyclyl)-glycoside derivatives useful as dual SGLT1 / SGLT2 modulators
JANSSEN PHARMACEUTICA NV0 citations51
US9012412B2Apr 21, 2015
Dual SGLT1/SGLT2 inhibitors
JANSSEN PHARMACEUTICA NV0 citations51
US11897880B2Feb 13, 2024
7,8-dihydrobenzo[e]pyrido[3,4-c]azocine-2,5(3H,6H)-dione derivatives useful as a factor XIa inhibitors
JANSSEN PHARMACEUTICA NV0 citations50
US11845748B2Dec 19, 2023
Bicyclic pyridine N-oxide derivatives useful as a factor XIa inhibitors
JANSSEN PHARMACEUTICA NV0 citations50
US11919881B2Mar 5, 2024
Substituted pyridine N-oxide derivatives useful as a factor XIa inhibitors
JANSSEN PHARMACEUTICA NV0 citations49
US11814364B2Nov 14, 2023
Pyridine N-oxide derivatives useful as factor XIa inhibitors
JANSSEN PHARMACEUTICA NV0 citations48
US8344009B2Jan 1, 2013
Substituted phenoxy thiazolidinediones as estrogen related receptor-á modulators
JANSSEN PHARMACEUTICA NV1 citations48
US7825244B2Nov 2, 2010
Intermediates useful in the synthesis of alkylquinoline and alkylquinazoline kinase modulators, and related methods of synthesis
JANSSEN PHARMACEUTICA NV1 citations47
US10251864B2Apr 9, 2019
Indole derivatives useful as glucagon receptor antagonists
JANSSEN PHARMACEUTICA NV0 citations40
US7893064B2Feb 22, 2011
Hydrazone derivatives as kinase inhibitors
JANSSEN PHARMACEUTICA NV0 citations40
US10815210B2Oct 27, 2020
Benzocyclobutane derivatives useful as dual SGLT1 / SGLT2 modulators
JANSSEN PHARMACEUTICA NV0 citations39
BIGNAN GILLES
5 patentsUS8796256B2Aug 5, 2014
Substituted thiazolidinedione indazoles, indoles and benzotriazoles as estrogen-related receptor-α modulators
BIGNAN GILLES3 citations60
US8445690B2May 21, 2013
Aminothiazolones as estrogen related receptor-alpha modulators
BIGNAN GILLES4 citations60
US8263781B2Sep 11, 2012
Substituted aminothiazolone indazoles as estrogen related receptor-alpha modulators
BIGNAN GILLES3 citations60
US8426604B2Apr 23, 2013
Aminothiazolones as estrogen related receptor-alpha modulators
BIGNAN GILLES1 citations50
US8399681B2Mar 19, 2013
Substituted aminothiazolone indazoles as estrogen related receptor-alpha modulators
BIGNAN GILLES1 citations50